Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Johnson and Johnson
Medtronic
McKinsey
Mallinckrodt

Last Updated: May 19, 2022

CLINICAL TRIALS PROFILE FOR PARICALCITOL


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Paricalcitol

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00048438 ↗ Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) Completed Abbott Phase 3 2002-02-01 The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney disease.
NCT00048451 ↗ Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly) Completed Abbott Phase 3 2002-02-01 The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney disease.
NCT00048516 ↗ Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing) Completed Abbott Phase 3 2002-02-01 The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney disease.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Paricalcitol

Condition Name

Condition Name for Paricalcitol
Intervention Trials
Secondary Hyperparathyroidism 22
Chronic Kidney Disease 21
Pancreatic Cancer 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Paricalcitol
Intervention Trials
Kidney Diseases 50
Renal Insufficiency, Chronic 43
Hyperparathyroidism 33
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Paricalcitol

Trials by Country

Trials by Country for Paricalcitol
Location Trials
United States 204
Spain 18
Italy 12
Malaysia 7
Poland 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Paricalcitol
Location Trials
New York 13
California 13
Texas 12
Pennsylvania 12
Arizona 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Paricalcitol

Clinical Trial Phase

Clinical Trial Phase for Paricalcitol
Clinical Trial Phase Trials
Phase 4 25
Phase 3 21
Phase 2 21
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Paricalcitol
Clinical Trial Phase Trials
Completed 62
Terminated 11
Recruiting 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Paricalcitol

Sponsor Name

Sponsor Name for Paricalcitol
Sponsor Trials
Abbott 36
AbbVie (prior sponsor, Abbott) 6
National Cancer Institute (NCI) 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Paricalcitol
Sponsor Trials
Other 104
Industry 64
NIH 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
McKesson
Medtronic
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.